| Literature DB >> 25534886 |
Alain Cohen-Solal1, Said Laribi2, Shiro Ishihara3, Giuseppe Vergaro4, Mathilde Baudet5, Damien Logeart6, Alexandre Mebazaa7, Etienne Gayat7, Nicolas Vodovar8, Domingo A Pascual-Figal9, Marie-France Seronde10.
Abstract
Rapidly assessing outcome in patients with acute decompensated heart failure is important but prognostic factors may differ from those used routinely for stable chronic heart failure. Multiple plasma biomarkers, besides the classic natriuretic peptides, have recently emerged as potential prognosticators. Furthermore, prognostic scores that combine clinical and biochemical data may also be useful. However, compared with the scores used in chronic heart failure, scores for acute decompensated heart failure have not been validated. This article reviews potential biomarkers, with a special focus on biochemical biomarkers, and possible prognostic scores that could be used by the clinician when assessing outcome in patients with acute heart failure.Entities:
Keywords: Acute decompensated heart failure; Biomarkers; Biomarqueurs; Insuffisance cardiaque aiguë; Natriuretic peptides; Peptides natriurétiques; Prognosis; Pronostic; Scores; Scores de risque
Mesh：
Substances：
Year: 2014 PMID： 25534886 DOI： 10.1016/j.acvd.2014.10.002
Source DB: PubMed Journal: Arch Cardiovasc Dis ISSN： 1875-2128 Impact factor: 2.340